Can u give sturgeon 25 with vertin
Reading File
Asking for Preferences
Finding Sources
Finding Sources
Searching the Web
Stugeron 25 cinnarizine with Vertin betahistine combination vertigo
Reading Web Page
https://www.droracle.ai/articles/824432/is-it-rational-to-pr…
Finding Sources
Reading File
Here's a comprehensive overview of Stugeron 25 (cinnarizine 25 mg) combined with Vertin (betahistine):
Stugeron 25 (Cinnarizine) + Vertin (Betahistine) — Drug Overview
Individual Mechanisms
| Drug | Class | Mechanism |
|---|---|---|
| Cinnarizine (Stugeron 25) | Calcium channel blocker / H1 antihistamine | Blocks Ca²⁺ channels in vestibular hair cells → reduces sensitivity; also has antihistaminic and anti-dopaminergic effects |
| Betahistine (Vertin 8/16/24 mg) | H1 agonist / H3 antagonist | Increases cochlear and labyrinthine blood flow; decreases peripheral vestibular firing; may facilitate vestibular compensation |
Is the Combination Rational?
Yes — with nuance. The two drugs work via complementary mechanisms, and their combination has been studied, particularly in Ménière's disease (MD).
A PMC-published Italian study (2015) specifically evaluated betahistine + cinnarizine in MD patients poorly responsive to betahistine alone:
- MD with migraine: Vertigo spells reduced from 9.4 → 3.8 (p = 0.0001); headaches reduced from 3.8 → 1.0 (p = 0.0001)
- MD without migraine: Vertigo spells reduced from 6.8 → 5.9 (p = 0.01)
- Combination was particularly effective in MD patients with comorbid migraine, as cinnarizine also acts as a calcium-channel-based migraine prophylactic
Common Clinical Uses
- Ménière's disease — especially when betahistine monotherapy is insufficient
- Peripheral vertigo (labyrinthitis, vestibular neuritis) — short-term symptom relief
- Vestibular migraine — cinnarizine adds migraine prophylaxis value
- Motion sickness — cinnarizine is a classic choice
Dosing
| Drug | Typical Dose |
|---|---|
| Cinnarizine (Stugeron) | 25 mg TDS (three times daily) with food |
| Betahistine (Vertin) | 8–16 mg TDS, or 24 mg BD; up to 48 mg/day is evidence-based |
Precautions for the Combination
- Parkinsonism risk: Cinnarizine has dopamine-blocking activity and can cause or worsen drug-induced parkinsonism, especially with prolonged use or in elderly patients. It should be used at the lowest effective dose and for the shortest duration possible. (Bradley & Daroff's Neurology)
- Anticholinergic burden: Cinnarizine carries a mild anticholinergic load (rated "1" on the anticholinergic burden scale). Combining with other anticholinergic agents increases risk of sedation and confusion.
- Sedation: Both drugs can cause drowsiness — warn patients about driving/operating machinery.
- Avoid in Parkinson's disease: Cinnarizine is contraindicated.
- Pregnancy/breastfeeding: Use with caution; limited safety data.
Bottom Line
Cinnarizine + betahistine is a rational and commonly prescribed combination in vertigo/Ménière's, particularly when single-agent therapy is inadequate. The combination is especially beneficial in patients with vestibular migraine comorbidity. However, keep cinnarizine use short-term to minimize extrapyramidal side effects.
Tintinalli's Emergency Medicine notes: "Calcium channel blockers [cinnarizine] are indicated for symptomatic relief of vertigo in patients not responding to scopolamine or antihistamines" as second-line therapy.
This is a shared conversation. Sign in to Orris to start your own chat.